Ergoteles’s Meridian Bioscience Inc VIVO Stock Holding History

Ergoteles’s Portfolio VIVO Stock Details VIVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-382,525	Closed	-$12.7M	–	2008
2022 Q4	$12.7M	Buy	382,525 +299,637	+361%	+$9.65M	0.47%	46
2022 Q3	$2.61M	Buy	+82,888	New	+$2.68M	0.09%	217
2021 Q3	–	Sell	-11,500	Closed	-$255K	–	1822
2021 Q2	$255K	Buy	+11,500	New	+$244K	0.01%	1152

Other funds holding VIVO

BTI

Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Ergoteles's VIVO Position: Q1 2023 in Review

Ergoteles sold out of Meridian Bioscience Inc (VIVO) in Q1 2023, closing a stake of 382,525 shares — an estimated $12.7M sold.

Ergoteles first reported a position in VIVO in Q2 2021 and held it in 3 quarters. The position peaked at $12.7M in Q4 2022. 2 funds tracked by Wall St. Rank hold VIVO as of Q1 2023.

Ergoteles reported no remaining Meridian Bioscience Inc position as of Q1 2023 after selling out during the quarter.
Ergoteles sold 382,525 Meridian Bioscience Inc shares in Q1 2023, an estimated $12.7M.
Ergoteles first reported a position in Meridian Bioscience Inc in Q2 2021 and held it in 3 quarters.
Ergoteles's Meridian Bioscience Inc position peaked at $12.7M in Q4 2022.
2 funds tracked by Wall St. Rank held Meridian Bioscience Inc as of Q1 2023.

Based on Ergoteles's 13F filing for Q1 2023, filed 10 May 2023.